Display options
Cite
Pagoni M, Garofalaki M, Panitsas F, et al. Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era. Mediterr J Hematol Infect Dis. 2011;3(1):e2011053doi: 10.4084/MJHID.2011.053.
Pagoni, M., Garofalaki, M., Panitsas, F., Manola, K., Psarra, K., Economopoulos, P., Vourtsi, A., Antoniades, M., Gkirkas, K., Tzouvara, E., Katis, F., Prokopiou, C., Tziotziou, I., Balta, A., Lemissiou, E., Tsirigotis, P., Repoussis, P., & Harhalakis, N. (2011). Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era. Mediterranean journal of hematology and infectious diseases, 3(1), e2011053. https://doi.org/10.4084/MJHID.2011.053
Pagoni, Maria, et al. "Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era." Mediterranean journal of hematology and infectious diseases vol. 3,1 (2011): e2011053. doi: https://doi.org/10.4084/MJHID.2011.053
Pagoni M, Garofalaki M, Panitsas F, Manola K, Psarra K, Economopoulos P, Vourtsi A, Antoniades M, Gkirkas K, Tzouvara E, Katis F, Prokopiou C, Tziotziou I, Balta A, Lemissiou E, Tsirigotis P, Repoussis P, Harhalakis N. Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era. Mediterr J Hematol Infect Dis. 2011;3(1):e2011053. doi: 10.4084/MJHID.2011.053. Epub 2011 Nov 28. PMID: 22220250; PMCID: PMC3248330.
Copy Download .nbib Format: NLM
Share it on

Mediterr J Hematol Infect Dis. 2011;3(1):e2011053. doi: 10.4084/MJHID.2011.053. Epub 2011 Nov 28.

Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era.

Mediterranean journal of hematology and infectious diseases

Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos, Aggeliki Vourtsi, Marios Antoniades, Kostas Gkirkas, Evangelia Tzouvara, Fotis Katis, Chrystalla Prokopiou, Irene Tziotziou, Artemis Balta, Eleni Lemissiou, Panagiotis Tsirigotis, Panagiotis Repoussis, Nicolas Harhalakis

Affiliations

  1. Hematology-Lymphoma Department - BMT Unit, Evangelismos Hospital, Athens, Greece.

PMID: 22220250 PMCID: PMC3248330 DOI: 10.4084/MJHID.2011.053

Abstract

Acute promyelocytic leukemia (APL) is highly curable with the combination of all-transretinoic acid (ATRA) and anthracycline based chemotherapy, but the percentage of early deaths remains high. In the present study, we report the clinical, immunophenotypic, cytogenetic and molecular characteristics and outcome of APL patients diagnosed and treated in various Hospitals of Greece and Cyprus.We describe the data of ninety-five APL patients who were diagnosed during the last 15 years. Seven (7.4%) newly diagnosed APL patients died due to intracranial hemorrhage within 72 hours of presentation. All but two patients were induced with ATRA alone or ATRA plus chemotherapy. The early death rate was 14.9%. After induction all 80 evaluable patients achieved complete hematologic remission. The cumulative incidence of relapse was 18.3%. Eight of the ten relapsed patients were successfully salvaged, while both patients with molecularly resistant disease died during salvage treatment. Overall survival (OS) at 5 years was 78.4% and disease free survival (DFS) 73.6%. In multivariate analysis of OS age over 60 years, DIC at diagnosis and marginally major hemorrhage at presentation were identified as adverse prognostic factors. In the subgroup of patients with available data on FLT3 mutation status (49 out of 94), ITD positivity also remained as an independent prognostic factor in the final model of OS, together with major hemorrhage and marginally high Sanz score. We found a close correlation between the CD2 expression and the development of the differentiation syndrome (DS). In conclusion, the main problem in managing patients with APL is still the high early death rate.

References

  1. Acta Med Scand. 1957 Nov 29;159(3):189-94 - PubMed
  2. Blood. 2009 Feb 26;113(9):1875-91 - PubMed
  3. Blood. 2010 Jan 14;115(2):326-30 - PubMed
  4. Haematologica. 2011 Apr;96(4):621-5 - PubMed
  5. Leuk Lymphoma. 2002 Dec;43(12):2409-11 - PubMed
  6. Cell. 1993 Aug 13;74(3):423-31 - PubMed
  7. Blood. 1999 Nov 1;94(9):3015-21 - PubMed
  8. Br J Haematol. 1976 Aug;33(4):451-8 - PubMed
  9. Lancet. 1977 Mar 5;1(8010):549-50 - PubMed
  10. Leuk Lymphoma. 1999 Apr;33(3-4):219-29 - PubMed
  11. Leuk Res. 2010 Jul;34(7):831-6 - PubMed
  12. Blood. 2002 Dec 15;100(13):4298-302 - PubMed
  13. Blood. 2009 Dec 10;114(25):5126-35 - PubMed
  14. Blood. 2008 Apr 1;111(7):3395-402 - PubMed
  15. Blood. 1993 Dec 1;82(11):3241-9 - PubMed
  16. Am J Clin Pathol. 2010 Mar;133(3):484-90 - PubMed
  17. Blood. 2008 Oct 15;112(8):3130-4 - PubMed
  18. Acta Haematol. 2004;112(1-2):55-67 - PubMed
  19. Best Pract Res Clin Haematol. 2003 Sep;16(3):387-408 - PubMed
  20. Haematologica. 2010 Mar;95(3):424-31 - PubMed
  21. Leukemia. 2002 Oct;16(10):1959-73 - PubMed
  22. Acta Haematol. 2010;123(3):162-70 - PubMed
  23. J Clin Oncol. 2006 Dec 20;24(36):5703-10 - PubMed
  24. Br J Haematol. 1996 Sep;94(3):557-73 - PubMed
  25. J Clin Oncol. 2003 Jun 1;21(11):2123-37 - PubMed
  26. Br J Haematol. 1996 Sep;94(3):493-500 - PubMed
  27. Blood. 1998 Oct 15;92(8):2712-8 - PubMed
  28. J Clin Oncol. 2010 Aug 20;28(24):3872-9 - PubMed
  29. Blood. 1997 Aug 1;90(3):1014-21 - PubMed
  30. Genes Chromosomes Cancer. 2003 Feb;36(2):175-88 - PubMed
  31. Blood. 2011 Aug 4;118(5):1248-54 - PubMed
  32. Blood. 2001 Sep 15;98(6):1752-9 - PubMed
  33. Blood. 2011 May 5;117(18):4716-25 - PubMed
  34. Cancer Genet Cytogenet. 2008 Apr 1;182(1):50-5 - PubMed
  35. Blood. 2004 Feb 15;103(4):1237-43 - PubMed
  36. Haematologica. 2001 Aug;86(8):807-13 - PubMed
  37. Blood. 1997 Aug 1;90(3):1321-5 - PubMed
  38. Ann Intern Med. 1992 Aug 15;117(4):292-6 - PubMed
  39. Leukemia. 2011 Apr;25(4):567-74 - PubMed
  40. Haematologica. 2007 Mar;92(3):315-22 - PubMed
  41. Blood. 2008 Feb 1;111(3):1078-84 - PubMed
  42. Leukemia. 2003 Dec;17(12):2318-57 - PubMed
  43. Blood. 2010 Oct 28;116(17):3171-9 - PubMed
  44. Leukemia. 2003 Jun;17(6):1013-34 - PubMed
  45. Blood. 2010 Nov 11;116(19):3751-7 - PubMed
  46. Leukemia. 1999 Aug;13(8):1294-5 - PubMed
  47. Haematologica. 2004 Jan;89(1):29-33 - PubMed
  48. Haematologica. 2001 Dec;86(12):1312-3 - PubMed
  49. Blood. 2001 Nov 1;98(9):2651-6 - PubMed
  50. Blood. 1999 Aug 15;94(4):1192-200 - PubMed
  51. Best Pract Res Clin Haematol. 2002 Mar;15(1):137-58 - PubMed
  52. Blood. 2002 Feb 1;99(3):822-4 - PubMed
  53. Leukemia. 1995 May;9(5):774-8 - PubMed
  54. Br J Haematol. 2000 Dec;111(3):801-6 - PubMed
  55. Haematologica. 1999 May;84(5):405-12 - PubMed
  56. Blood. 2007 Jul 1;110(1):59-66 - PubMed
  57. Blood. 1988 Aug;72(2):567-72 - PubMed
  58. Blood. 2002 Oct 1;100(7):2393-8 - PubMed
  59. Leukemia. 2007 Jan;21(1):4-8 - PubMed
  60. Blood. 2010 Mar 4;115(9):1690-6 - PubMed
  61. Schweiz Med Wochenschr. 1959 Jun 6;89:604-8 - PubMed
  62. Blood. 2000 Aug 15;96(4):1247-53 - PubMed
  63. Blood. 2008 Mar 1;111(5):2505-15 - PubMed
  64. Best Pract Res Clin Haematol. 2003 Sep;16(3):503-20 - PubMed
  65. Blood. 1999 Jul 1;94(1):12-22 - PubMed
  66. Leukemia. 1999 Dec;13(12):1901-28 - PubMed
  67. Br J Haematol. 1980 Jan;44(1):169-70 - PubMed
  68. J Clin Oncol. 2011 Feb 10;29(5):495-503 - PubMed
  69. Leukemia. 2011 Jul;25(7):1128-34 - PubMed
  70. Blood. 1999 May 15;93(10):3167-215 - PubMed
  71. Blood. 2010 Jun 24;115(25):5137-46 - PubMed
  72. Cancer Genet Cytogenet. 2000 Feb;117(1):82-3 - PubMed
  73. Am J Med. 1984 May;76(5):827-41 - PubMed
  74. Blood. 1996 Aug 15;88(4):1390-8 - PubMed
  75. Cell. 1991 Aug 23;66(4):663-74 - PubMed
  76. Blood. 1992 Jan 15;79(2):313-9 - PubMed
  77. Crit Rev Oncol Hematol. 2005 Nov;56(2):261-74 - PubMed
  78. Leukemia. 2002 Oct;16(10):1927-32 - PubMed
  79. J Clin Oncol. 1990 May;8(5):813-9 - PubMed
  80. Clin Adv Hematol Oncol. 2005 May;3(5):391-7, 429 - PubMed
  81. Am J Hematol. 2010 Dec;85(12):956-7 - PubMed
  82. Blood Rev. 2003 Jun;17(2):71-97 - PubMed
  83. Leuk Lymphoma. 2002 Feb;43(2):275-80 - PubMed
  84. Blood. 1997 Oct 1;90(7):2747-56 - PubMed
  85. Blood. 1990 Nov 1;76(9):1704-9 - PubMed
  86. Br J Haematol. 2005 Feb;128(3):407-9 - PubMed
  87. Haematologica. 2011 Jan;96(1):174-6 - PubMed
  88. Br J Haematol. 2004 May;125(4):463-9 - PubMed
  89. J Clin Pharm Ther. 2008 Aug;33(4):331-8 - PubMed
  90. Blood. 2002 Jul 1;100(1):59-66 - PubMed
  91. Leukemia. 2003 Aug;17(8):1600-4 - PubMed
  92. Blood. 1999 Oct 1;94(7):2225-9 - PubMed
  93. Leuk Lymphoma. 2004 Sep;45(9):1783-9 - PubMed
  94. Leukemia. 1994 Jun;8(6):929-33 - PubMed

Publication Types